PH24260A - Novel peptides - Google Patents

Novel peptides

Info

Publication number: PH24260A
Authority: PH; Philippines
Prior art keywords: insulin; charge; amino acid; neutral; novel peptides
Prior art date: 1985-03-12

Application number

PH33459A

Other languages

English (en)

Inventor

Jan Markussen

Original Assignee

Novo Industri As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-03-12

Filing date

1986-02-27

Publication date

1990-05-04

1986-02-27 Application filed by Novo Industri As filed Critical Novo Industri As

1990-05-04 Publication of PH24260A publication Critical patent/PH24260A/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Endocrinology (AREA)
Toxicology (AREA)
Diabetes (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

PH33459A 1985-03-12 1986-02-27 Novel peptides PH24260A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DK113585A DK113585D0 (da)	1985-03-12	1985-03-12	Nye peptider

Publications (1)

Publication Number	Publication Date
PH24260A true PH24260A (en)	1990-05-04

Family

ID=8101410

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH33459A PH24260A (en)	1985-03-12	1986-02-27	Novel peptides

Country Status (22)

Country	Link
EP (1)	EP0194864B1 (da)
JP (1)	JPS61212598A (da)
KR (1)	KR930007433B1 (da)
CN (1)	CN86101489A (da)
AT (1)	ATE77391T1 (da)
AU (1)	AU612964B2 (da)
CS (1)	CS259536B2 (da)
DD (1)	DD244345A5 (da)
DE (1)	DE3685668T2 (da)
DK (2)	DK113585D0 (da)
ES (1)	ES8800276A1 (da)
FI (1)	FI861007A7 (da)
GR (1)	GR860687B (da)
HU (1)	HU201097B (da)
IL (1)	IL78103A0 (da)
MY (1)	MY102102A (da)
NO (1)	NO172441C (da)
NZ (1)	NZ215445A (da)
PH (1)	PH24260A (da)
PT (1)	PT82173B (da)
YU (1)	YU46001B (da)
ZA (1)	ZA861432B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5008241A (en) *	1985-03-12	1991-04-16	Novo Nordisk A/S	Novel insulin peptides
DK347086D0 (da) *	1986-07-21	1986-07-21	Novo Industri As	Novel peptides
DK119785D0 (da) *	1985-03-15	1985-03-15	Nordisk Gentofte	Insulinpraeparat
DK437786D0 (da) *	1986-09-12	1986-09-12	Nordisk Gentofte	Insulinprecursorer
KR900701842A (ko) *	1988-07-20	1990-12-04	헨리 브뢰늄	인간 인슐린 동족체와 그를 포함하는 제제
DE3827533A1 (de) *	1988-08-13	1990-02-15	Hoechst Ag	Pharmazeutische zubereitung zur behandlung des diabetes mellitus
DE3837825A1 (de) *	1988-11-08	1990-05-10	Hoechst Ag	Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK134189D0 (da) *	1989-03-20	1989-03-20	Nordisk Gentofte	Insulinforbindelser
US5130298A (en) *	1989-05-16	1992-07-14	Ethicon, Inc.	Stabilized compositions containing epidermal growth factor
DE3936876A1 (de) *	1989-11-06	1991-05-23	Hoechst Ag	Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
AUPP609198A0 (en) *	1998-09-22	1998-10-15	Curtin University Of Technology	Use of non-peptidyl compounds for the treatment of insulin related ailments
US6933272B1 (en)	1998-09-22	2005-08-23	Erik Helmerhorst	Use of non-peptidyl compounds for the treatment of insulin related ailments
DE10114178A1 (de)	2001-03-23	2002-10-10	Aventis Pharma Gmbh	Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de)	2002-06-18	2004-01-15	Aventis Pharma Deutschland Gmbh	Saure Insulinzubereitungen mit verbesserter Stabilität
ES2642214T3 (es)	2004-01-21	2017-11-15	Novo Nordisk Health Care Ag	Conjugación de péptidos mediante transglutaminasa
US20090074882A1 (en)	2005-12-28	2009-03-19	Novo Nordisk A/S	Insulin compositions and method of making a composition
DE102006031955A1 (de) *	2006-07-11	2008-01-17	Sanofi-Aventis Deutschland Gmbh	Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
DE102006031962A1 (de) *	2006-07-11	2008-01-17	Sanofi-Aventis Deutschland Gmbh	Amidiertes Insulin Glargin
BRPI0907119A2 (pt) *	2008-01-09	2015-07-14	Sanofi Aventis Deutschland	Derivados de insulina tendo um perfil de ação de tempo extremamente retardado
DE102008003566A1 (de) *	2008-01-09	2009-07-16	Sanofi-Aventis Deutschland Gmbh	Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
AU2009203809B2 (en) *	2008-01-09	2013-07-25	Sanofi-Aventis Deutschland Gmbh	Novel insulin derivatives having an extremely delayed time-action profile
PT3228320T (pt)	2008-10-17	2020-03-26	Sanofi Aventis Deutschland	Combinação de uma insulina e de um agonista do glp-1
TW201105346A (en) *	2009-07-06	2011-02-16	Sanofi Aventis Deutschland	Heat-stable and vibration-stable insulin preparations
KR101853606B1 (ko)	2009-07-06	2018-05-03	사노피-아벤티스 도이칠란트 게엠베하	메티오닌을 함유하는 수성 인슐린 제제
KR101337322B1 (ko)	2009-11-13	2013-12-06	사노피-아벤티스 도이칠란트 게엠베하	Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
DK2498802T3 (da)	2009-11-13	2015-04-13	Sanofi Aventis Deutschland	Farmaceutisk præparat omfattende en glp-1-agonist, et insulin og en methionin
JP6249773B2 (ja) *	2010-05-10	2017-12-20	ノヴォノルディスクアー／エス	インスリン−亜鉛錯体の調製方法
ES2606554T3 (es)	2010-08-30	2017-03-24	Sanofi-Aventis Deutschland Gmbh	Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
CN102174495A (zh) *	2011-01-20	2011-09-07	马忠仁	一种提取糜胰蛋白酶的方法
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PL2750699T3 (pl)	2011-08-29	2015-12-31	Sanofi Aventis Deutschland	Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2
AR087744A1 (es)	2011-09-01	2014-04-16	Sanofi Aventis Deutschland	Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
AU2015359376B2 (en)	2014-12-12	2021-09-09	Sanofi-Aventis Deutschland Gmbh	Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
US10335464B1 (en)	2018-06-26	2019-07-02	Novo Nordisk A/S	Device for titrating basal insulin
US12343383B2 (en)	2019-07-12	2025-07-01	Novo Nordisk A/S	High concentration insulin formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK319780A (da) *	1980-07-24	1982-01-25	Forenede Bryggerier As	Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner
DE3326472A1 (de) *	1983-07-22	1985-02-14	Hoechst Ag, 6230 Frankfurt	Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3333640A1 (de) *	1983-09-17	1985-04-25	Hoechst Ag, 6230 Frankfurt	Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DK119785D0 (da) *	1985-03-15	1985-03-15	Nordisk Gentofte	Insulinpraeparat

1985
- 1985-03-12 DK DK113585A patent/DK113585D0/da unknown
1986
- 1986-02-26 ZA ZA861432A patent/ZA861432B/xx unknown
- 1986-02-27 PH PH33459A patent/PH24260A/en unknown
- 1986-03-10 YU YU34586A patent/YU46001B/sh unknown
- 1986-03-10 DD DD86287734A patent/DD244345A5/de not_active IP Right Cessation
- 1986-03-10 DK DK107086A patent/DK158677C/da active
- 1986-03-11 CS CS861666A patent/CS259536B2/cs unknown
- 1986-03-11 PT PT82173A patent/PT82173B/pt not_active IP Right Cessation
- 1986-03-11 EP EP86301755A patent/EP0194864B1/en not_active Expired - Lifetime
- 1986-03-11 DE DE8686301755T patent/DE3685668T2/de not_active Expired - Fee Related
- 1986-03-11 JP JP61051586A patent/JPS61212598A/ja active Pending
- 1986-03-11 IL IL78103A patent/IL78103A0/xx not_active IP Right Cessation
- 1986-03-11 AU AU54495/86A patent/AU612964B2/en not_active Ceased
- 1986-03-11 NZ NZ215445A patent/NZ215445A/xx unknown
- 1986-03-11 KR KR1019860001737A patent/KR930007433B1/ko not_active Expired - Lifetime
- 1986-03-11 HU HU861024A patent/HU201097B/hu not_active IP Right Cessation
- 1986-03-11 CN CN198686101489A patent/CN86101489A/zh active Pending
- 1986-03-11 ES ES552879A patent/ES8800276A1/es not_active Expired
- 1986-03-11 NO NO860920A patent/NO172441C/no unknown
- 1986-03-11 AT AT86301755T patent/ATE77391T1/de not_active IP Right Cessation
- 1986-03-11 FI FI861007A patent/FI861007A7/fi not_active Application Discontinuation
- 1986-03-12 GR GR860687A patent/GR860687B/el unknown
1987
- 1987-09-30 MY MYPI87002520A patent/MY102102A/en unknown

Also Published As

Publication number	Publication date
CN86101489A (zh)	1987-01-21
IL78103A0 (en)	1986-07-31
PT82173B (pt)	1988-07-29
ES8800276A1 (es)	1987-11-01
DE3685668T2 (de)	1993-01-14
DE3685668D1 (en)	1992-07-23
DK107086D0 (da)	1986-03-10
NO172441B (no)	1993-04-13
NO860920L (no)	1986-09-15
DD244345A5 (de)	1987-04-01
PT82173A (en)	1986-04-01
MY102102A (en)	1992-03-31
FI861007L (fi)	1986-09-13
DK158677C (da)	1990-12-31
NZ215445A (en)	1989-07-27
CS259536B2 (en)	1988-10-14
DK113585D0 (da)	1985-03-12
EP0194864B1 (en)	1992-06-17
CS166686A2 (en)	1987-12-17
YU46001B (sh)	1992-12-21
AU612964B2 (en)	1991-07-25
EP0194864A2 (en)	1986-09-17
ZA861432B (en)	1986-11-26
KR930007433B1 (ko)	1993-08-10
ES552879A0 (es)	1987-11-01
FI861007A7 (fi)	1986-09-13
KR860007288A (ko)	1986-10-10
JPS61212598A (ja)	1986-09-20
YU34586A (en)	1988-10-31
GR860687B (en)	1986-07-11
HUT41052A (en)	1987-03-30
EP0194864A3 (en)	1989-01-11
HU201097B (en)	1990-09-28
FI861007A0 (fi)	1986-03-11
DK158677B (da)	1990-07-02
NO172441C (no)	1993-07-21
AU5449586A (en)	1986-09-18
DK107086A (da)	1986-11-07
ATE77391T1 (de)	1992-07-15

Publication	Publication Date	Title
DE3685668D1 (en)	1992-07-23	Peptide.
MY102873A (en)	1993-03-31	Novel peptides
NO912438D0 (no)	1991-06-21	Humaninsulinanaloger.
GB2181647B (en)	1989-10-11	Compositions based on lysine and arginine salts.
ES2012720A6 (es)	1990-04-01	Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
IE873239L (en)	1988-06-01	Variants of hirudin
GB2171698B (en)	1989-02-01	Ester substituted aminoalkanoylureido amino and imino acid and ester compounds
IL78951A (en)	1990-11-05	Compounds with the activity
DK376187A (da)	1988-01-22	Peptider
GB2113205B (en)	1986-03-26	S-substituted 2-azido-3-mercapto-propionic acid esters and use in production of cysteine and derivatives